CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Haemato AG Company Snapshot
Haemato AG operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Haemato AG with three other drug stores in Europe: Medios AG (2017 sales of 253.64 million Euro [US$287.57 million] of which 83% was SPECIALTY-PHARMA TRADE), Salus Ljubljana DD of Slovenia (232.70 million Euro [US$263.83 million] ), and Sopharma Trading AD which is based in Bulgaria (729.59 million Bulgarian Lev [US$422.95 million] ).

Sales Analysis. Haemato AG reported sales of 289.86 million Euro (US$328.64 million) for the year ending December of 2017. This represents an increase of 5.2% versus 2016, when the company's sales were 275.61 million Euro. Sales at Haemato AG have increased during each of the previous five years (and since 2012, sales have increased a total of 767%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Haemato AG
  Stock Performance Chart for Haemato AG
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 5.12
(Figures in Euro)
1 Week -0.4%   13 Weeks 1.2%  
4 Weeks -5.2%   52 Weeks -9.0%  
 
Haemato AG Key Data:
  Ticker: HAE Country: Germany
  Exchanges: FRA Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2017 Sales 289,862,246
(Year Ending Jan 2018).
Employees: 195
  Currency: Euro Market Cap: 112,537,600
  Fiscal Yr Ends: December Shares Outstanding: 21,980,000
  Share Type: Inhaberstammaktien Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.